Biovie (BIVI) EBIAT: 2017-2025
Historic EBIAT for Biovie (BIVI) over the last 7 years, with Jun 2025 value amounting to -$3.5 million.
- Biovie's EBIAT rose 29.38% to -$3.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$17.5 million, marking a year-over-year increase of 45.39%. This contributed to the annual value of -$17.5 million for FY2025, which is 45.39% up from last year.
- Per Biovie's latest filing, its EBIAT stood at -$3.5 million for Q2 2025, which was down 25.13% from -$2.8 million recorded in Q1 2025.
- Biovie's EBIAT's 5-year high stood at -$2.8 million during Q1 2025, with a 5-year trough of -$131.5 million in Q2 2021.
- For the 3-year period, Biovie's EBIAT averaged around -$7.4 million, with its median value being -$7.6 million (2024).
- Per our database at Business Quant, Biovie's EBIAT plummeted by 716.83% in 2021 and then surged by 93.85% in 2022.
- Biovie's EBIAT (Quarterly) stood at -$5.4 million in 2021, then crashed by 189.73% to -$15.7 million in 2022, then spiked by 46.44% to -$8.4 million in 2023, then grew by 15.34% to -$7.1 million in 2024, then rose by 29.38% to -$3.5 million in 2025.
- Its last three reported values are -$3.5 million in Q2 2025, -$2.8 million for Q1 2025, and -$7.1 million during Q4 2024.